The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models

The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models

<b>Background.</b> Glioblastoma multiforme (GBM) is a devastating disease showing a very poor prognosis. New therapeutic approaches are needed to improve survival and quality of life. GBM is a highly vascularized tumor and as such, chemotherapy and anti-angiogenic drugs have been combine...

Full description

Bibliographic Details
Main Authors: Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, Simona Delle Monache, Roberta Sferra, Simona Pompili, Flora Vitale, Stefano Martellucci, Francesco Marampon, Vincenzo Mattei, Leda Biordi, David Sherris, Claudio Festuccia
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Cancers
Subjects:
glioblastoma
res529
torc1/torc2 inhibitor
bevacizumab
Online Access:https://www.mdpi.com/2072-6694/11/10/1604

Similar Items

Similar Items